Fenofibrate Exerts Antitumor Effects in Colon Cancer via Regulation of DNMT1 and CDKN2A
Peroxisome proliferator-activated receptor alpha (PPARA) is the molecular target of fibrates commonly used to treat dyslipidemia and diabetes. Recently, the potential role of PPARA in other pathological conditions, such as cancers, has been recognized. Here, using bioinformatics analysis, we found t...
Saved in:
Main Authors: | Rui Kong, Nan Wang, Wei Han, Wen Bao, Jie Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2021/6663782 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis
by: Wen Bao, et al.
Published: (2021-01-01) -
Metformin exerted tumoricidal effects on colon cancer tumoroids via the regulation of autophagy pathway
by: Roya Shabkhizan, et al.
Published: (2025-02-01) -
Correlations among PPAR𝜸, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer
by: Valerio Pazienza, et al.
Published: (2012-01-01) -
Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
by: Liu Rui, et al.
Published: (2023-06-01) -
Fenofibrate Inhibited the Differentiation of T Helper 17 Cells In Vitro
by: Zhou Zhou, et al.
Published: (2012-01-01)